Connect with us


Greece: MEP Stelios Kouloglou questions European Commission about patients' lack of access to cannabis



Greek MEP Stelios Kouloglou. Photo: DR

Like Portugal, Greek patients also face difficulties in accessing treatments with medicinal cannabis and its derivatives. The fact that, over the last two years, patients in Greece have not had access to medicinal cannabis preparations, forcing them to resort to illegal channels for their supply, has now been brought to the attention of the European Commission (EC) by MEP Stelios Kouloglou.

Explaining that this situation is the result of Greek government regulations, which violate the fundamental principle of the free movement of goods and create conditions of unfair competition in the single market, the MEP asked the EC to clarify how it intends to address the issue. Kouloglou specifically asked about how the Commission intends to regulate the matter within the scope of a European legislative framework, which discourages the illegal market and which results in regulated quality, accurate labeling and which guarantees legal and safe access to patients.

Read below the full text and questions sent by Greek MEP, Stelios Kouloglou, to the EC.

“Violations of EU fundamental principles and the lack of a European framework for medicinal cannabis lead patients to the black market. The use of cannabis for medicinal purposes is universally accepted. The World Health Organization proposes prescribing it for a wide range of conditions and the European Parliament has called on European and national authorities to address the issue legislatively, fund research and innovation and provide information to healthcare professionals. Medical cannabis has been legalized in Greece since 2017, for the cultivation and production of products with a THC content greater than 0,3%, but patients. Currently, they do not have access to formulations and the few national investment sources have been slow to produce.
Furthermore, in November 2021, the Greek government banned the import of medicinal cannabis products, in violation of Article 28 of the TFEU (Treaty on the Functioning of the European Union), creating oligopolistic conditions in the country. As a result, patients have been forced to turn to the illegal market to treat numerous health conditions.

We call on the Commission:
1 – How does the Commission intend to address the shortage of medicinal cannabis products for patients, which has been created due to regulations that violate the fundamental principle of the free movement of goods and that create conditions of unfair competition in the unified market?
2 – Does the Commission intend to regulate the issue comprehensively within the scope of a European legislative framework that effectively limits the black market, regulates quality and accurate labeling and guarantees legal and safe access to medicines for medicinal use?”



[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]


What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Notify of

Inline feedback
View all comments

Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International1 hours ago

USA: Pediatrician Bonni Goldstein launches petition against ban on natural CBD medicines in California

North American pediatrician Bonni Goldstein is warning of the attempt to ban medicines derived from natural CBD in...

International1 hours ago

Europe has almost 23 million users of cannabis, the most consumed of all illicit substances

Cannabis continues to be, by far, the most consumed illicit substance in Europe. These are the conclusions of the “Report...

Events2 days ago

Mary Jane celebrates legal cannabis culture for the first time in Germany

It is next weekend, from the 14th to the 16th of June, that the usual Mary Jane will take place, at the Messe...

Events1 weeks ago

CB Club brings together cannabis professionals in anticipation of Mary Jane, in Berlin

In anticipation of the CB Expo (Cannabis Business Expo and Conference), which will take place in Dortmund, in September, the CB Company will...

report1 weeks ago

South Africa: the legalization of an already thriving industry

In the weeks leading up to the General Assembly elections in South Africa, last Wednesday, May 29, there were...

Interviews1 weeks ago

Rui Reininho: “I think it's really weird that my GNR colleagues are poking their noses into people's properties to see what this plant does”

Rui Reininho, Portuguese musician who became famous as the lead singer of GNR, needs no introduction. Contrary to what many people think, he did not found...

News2 weeks ago

Canada: Study shows that using cannabis reduces methamphetamine consumption

Polydrug users, individuals who consume several substances, often turn to cannabis as a way to reduce their consumption...

Events4 weeks ago

CannaTrade returns to Zurich from May 24th to 26th

CannaTrade – Zurich International Hemp Fair and Festival comes of age in 2024, celebrating its 18th...

Press Releases4 weeks ago

SOMAÍ Group and its subsidiary RPK Biopharma expand partnership with Cookies to include Europe and the United Kingdom

LISBON, PORTUGAL, May 16, 2024 / — The SOMAÍ Group (“SOMAÍ”) and its subsidiary, RPK Biopharma expanded...

National4 weeks ago

Portugal: Estimated CBD consumption increases despite ban

The “Cannabis in Portugal” report, carried out by Euromonitor International, released the most recent data on the cannabis industry,...